{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:39:33Z","timestamp":1780709973177,"version":"3.54.1"},"reference-count":25,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2020,4,26]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Cystic Fibrosis (CF) is a genetic disease which affects the patient\u2019s lungs,\npancreas, liver, kidney and intestine and lacks sulfatase enzyme, leading to mucopolysaccharidosis.\nColistin sulfate acts by interacting with phospholipids of bacterial cell membranes. Sulfatase enzyme\nreduces the high levels of sulfated glycosaminoglycans and glycolipids by the hydrolysis of sulfate\nesters in lysosome.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The aim of the present investigation was to prepare and evaluate dextran microparticulate\ninhalable dry powder for the efficient targeting of colistin sulfate at affected area of lung without\ncausing the side effects in the treatment of CF and mucopolysaccharidosis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Microparticulate dry powder was prepared by the lyophilization method and evaluated for\nparticle size, % yield, % drug content, solid state characterization, in-vitro lung deposition study, and\nin-vitro drug release study.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Particle size, % yield and % drug content were found to be 4.03 \u00b1 0.196 \u00b5m, 94.02 % and\n99.45 \u00b1 0.015% respectively. Bulk density, tapped density, hausner\u2019s ratio, carr\u2019s index and angle of\nrepose of optimized batch were found to be 0.216 \u00b1 0.025 g\/cm3, 0.236 \u00b1 0.035 g\/cm3, 1.09 \u00b1 0.026,\n8.47 \u00b1 0.025 % and 26.10 \u00b1 0.029\u02da respectively. A fine particle fraction, fine particle dose, mass median\naerodynamic diameter, geometric standard deviation and emitted dose were found to be 66.78%, 16.45\nmg, 4.89 \u00b5m, 1.32 and 246.33 mg respectively. The % CDR of optimized batch was found to be 96.12 \u00b1\n0.049 % at 24 h.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Based on the obtained results, we conclude that dextran microparticulate inhalable dry\npowder might be suitable carrier for the delivery of colistin sulfate and sulfatase in combination via\npulmonary route for the treatment of cystic fibrosis and mucopolysaccharidosis.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567201817666200122160110","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T07:17:50Z","timestamp":1579763870000},"page":"218-228","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dextran Microparticulate Inhalable Dry Powder for the Treatment of Cystic Fibrosis and Mucopolysaccharidosis"],"prefix":"10.2174","volume":"17","author":[{"given":"Neel R.","family":"Solanki","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, Faculty of Pharmacy, Parul Institute of Pharmacy and Research, Parul University, P.O. Limda, Ta: Waghodia, Dist. Vadodara-391760, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5215-5774","authenticated-orcid":true,"given":"Deepa H.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Faculty of Pharmacy, Parul Institute of Pharmacy and Research, Parul University, P.O. Limda, Ta: Waghodia, Dist. Vadodara-391760, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipali R.","family":"Talele","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, Faculty of Pharmacy, Parul Institute of Pharmacy and Research, Parul University, P.O. Limda, Ta: Waghodia, Dist. Vadodara-391760, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.2475911","volume":"245","author":"Riordan J.R.","year":"1989","unstructured":"Riordan J.R.; Rommens J.M.; Kerem B.; Alon N.; Rozmahel R.; Grzelczak Z.; Zielenski J.; Lok S.; Plavsic N.; Chou J.L.; Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989,245(4922),1066-1073","journal-title":"Science"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","volume":"373","author":"O\u2019Sullivan B.P.","year":"2009","unstructured":"O\u2019Sullivan B.P.; Freedman S.D.; Cystic fibrosis. Lancet 2009,373(9678),1891-1904","journal-title":"Lancet"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/BF00331273","volume":"218","author":"de Hostos E.L.","year":"1989","unstructured":"de Hostos E.L.; Schilling J.; Grossman A.R.; Structure and expression of the gene encoding the periplasmic arylsulfatase of Chlamydomonas reinhardtii. Mol Gen Genet 1989,218(2),229-239","journal-title":"Mol Gen Genet"},{"key":"ref=4","first-page":"5115","volume":"3","year":"2017","unstructured":"Mucopolysaccharidoses Fact Sheet, NINDS, NIH Publication 2017,3,5115"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1093\/infdis\/124.6.610","volume":"124","author":"Davis S.D.","year":"1971","unstructured":"Davis S.D.; Iannetta A.; Wedgwood R.J.; Activity of colistin against Pseudomonas aeruginosa: inhibition by calcium. J Infect Dis 1971,124(6),610-612","journal-title":"J Infect Dis"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1128\/MMBR.20.1.14-27.1956","volume":"20","author":"Newton B.A.","year":"1956","unstructured":"Newton B.A.; The properties and mode of action of the polymyxins. Bacteriol Rev 1956,20(1),14-27","journal-title":"Bacteriol Rev"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1021\/bi00587a024","volume":"18","author":"Schindler M.","year":"1979","unstructured":"Schindler M.; Osborn M.J.; Interaction of divalent cations and polymyxin B with lipopolysaccharide. Biochemistry 1979,18(20),4425-4430","journal-title":"Biochemistry"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1586\/14787210.6.5.593","volume":"6","author":"Falagas M.E.","year":"2008","unstructured":"Falagas M.E.; Grammatikos A.P.; Michalopoulos A.; Potential of old-generation antibiotics to address current need for new antibiotics. Expert Rev Anti Infect Ther 2008,6(5),593-600","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1097\/00063198-200111000-00013","volume":"7","author":"Beringer P.","year":"2001","unstructured":"Beringer P.; The clinical use of colistin in patients with cystic fibrosis. Curr Opin Pulm Med 2001,7(6),434-440","journal-title":"Curr Opin Pulm Med"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1533\/9781845696344","author":"Fellows P.J.","year":"2009","unstructured":"Fellows P.J.;  Food processing technology: principles and practice. 1st Ed. Elsevier, Woodhead Publishers, IL, USA 2009,928"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1007\/s11095-013-1015-6","volume":"30","author":"Claus S.","year":"2013","unstructured":"Claus S.; Weiler C.; Schiewe J.; Friess W.; Optimization of the fine particle fraction of a lyophilized lysozyme formulation for dry powder inhalation. Pharm Res 2013,30(6),1698-1713","journal-title":"Pharm Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.3109\/03639045.2015.1062897","volume":"41","author":"Hanafy A.S.","year":"2015","unstructured":"Hanafy A.S.; Farid R.M.; ElGamal S.S.; Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer\u2019s disease management: preparation and detection in rat brain. Drug Dev Ind Pharm 2015,41(12),2055-2068","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/10837450601166536","volume":"12","author":"Saini D.","year":"2007","unstructured":"Saini D.; Biris A.S.; Srirama P.K.; Mazumder M.K.; Particle size and charge distribution analysis of pharmaceutical aerosols generated by inhalers. Pharm Dev Technol 2007,12(1),35-41","journal-title":"Pharm Dev Technol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1155\/2015\/624316","volume":"2015","author":"Mutasim E.M.","year":"2015","unstructured":"Mutasim E.M.; Wagiealla S.S.; Ahmed G.E.; Awadalla M.M.; Derivative spectrophotometric methods for the analysis and stability studies of colistin sulphate. J Chem 2015,2015,5","journal-title":"J Chem"},{"key":"ref=15","first-page":"126","volume":"10","author":"Saleem I.","year":"2007","unstructured":"Saleem I.; Donovan M.J.; Smyth H.D.; Particle size analysis: From microparticles to nanosystems. Am Pharmaceut Rev 2007,10(1),126-130","journal-title":"Am Pharmaceut Rev"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ijpharm.2014.11.068","volume":"478","author":"Huang Z.","year":"2015","unstructured":"Huang Z.; Scicolone J.V.; Han X.; Dav\u00e9 R.N.; Improved blend and tablet properties of fine pharmaceutical powders via dry particle coating. Int J Pharm 2015,478(2),447-455","journal-title":"Int J Pharm"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.powtec.2015.11.044","volume":"289","author":"Sun C.C.","year":"2016","unstructured":"Sun C.C.; Quantifying effects of moisture content on flow properties of microcrystalline cellulose using a ring shear tester. Powder Technol 2016,289,104-108","journal-title":"Powder Technol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4103\/0250-474X.180261","volume":"78","author":"Kumaresan C.","year":"2016","unstructured":"Kumaresan C.; Sathishkumar K.; Development of an inhaled sustained release dry powder formulation of salbutamol sulphate, an antiasthmatic drug. Indian J Pharm Sci 2016,78(1),136-142","journal-title":"Indian J Pharm Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1208\/s12249-009-9280-8","volume":"10","author":"Puthli S.","year":"2009","unstructured":"Puthli S.; Vavia P.R.; Stability studies of microparticulate system with piroxicam as model drug. AAPS PharmSciTech 2009,10(3),872-880","journal-title":"AAPS PharmSciTech"},{"key":"ref=20","first-page":"365","volume":"7","author":"Saharan P.","year":"2015","unstructured":"Saharan P.; Bhatt D.; Saharan S.P.; Bahmani K.; To study the effect of polymer and surfactant concentration on characteristics of nanoparticle formulations. Scholars Res Libr 2015,7(12),365-371","journal-title":"Scholars Res Libr"},{"key":"ref=21","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7834159","volume":"2018","author":"Teja S.P.S.","year":"2018","unstructured":"Teja S.P.S.; Damodharan N.; 2 full factorial model for particle size optimization of methotrexate loaded chitosan nanocarriers: a Design of Experiments (DoE) approach. BioMed Res Int 2018,2018","journal-title":"BioMed Res Int"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/jps.21085","volume":"97","author":"Abdul-Fattah A.M.","year":"2008","unstructured":"Abdul-Fattah A.M.; Lechuga-Ballesteros D.; Kalonia D.S.; Pikal M.J.; The impact of drying method and formulation on the physical properties and stability of methionyl human growth hormone in the amorphous solid state. J Pharm Sci 2008,97(1),163-184","journal-title":"J Pharm Sci"},{"key":"ref=23","first-page":"513","volume":"10","author":"Yang F.","year":"2015","unstructured":"Yang F.; Liu X.; Wang W.; Liu C.; Quan L.; Liao Y.; The effects of surface morphology on the aerosol performance of spray-dried particles within HFA 134a based metered dose formulations. Asian J Pharmaceut Sci 2015,10(6),513-519","journal-title":"Asian J Pharmaceut Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1046\/j.1365-2125.2003.01893.x","volume":"56","author":"Labiris N.R.","year":"2003","unstructured":"Labiris N.R.; Dolovich M.B.; Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 2003,56(6),600-612","journal-title":"Br J Clin Pharmacol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1002\/jps.23176","volume":"101","author":"El-Gendy N.","year":"2012","unstructured":"El-Gendy N.; Huang S.; Selvam P.; Soni P.; Berkland C.; Development of budesonide nanocluster dry powder aerosols: formulation and stability. J Pharm Sci 2012,101(9),3445-3455","journal-title":"J Pharm Sci"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/178522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T18:54:06Z","timestamp":1591124046000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/178522\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,26]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,4,26]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201817666200122160110","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,26]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-07-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}